Distribution in the Body of Targeted Ursolic Acid Liposomes and Their Inhibitory Effect on Mice Transplanted Tumor
YANG Guang1,2, CHEN Xiao-qing1
1. School of Medicine, Jianghan University, Wuhan 430056, China; 2. Pharmacy School, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Abstract��OBJECTIVE To study the distribution of folate receptor targeted ursolic acid liposomes and evaluate its antitumor effects on human epidermoid carcinoma xenografts in nude mice. METHODS Folate derivative was used as targeting molecule and conjugated with mPEG-DSPE for obtaining liposome with long circulation features. This novel targeted agent was prepared by a thin-film dispersion method and ursolic acid was loaded into the liposomes as the anticancer drugs. Tissue distribution of liposomes in heart, liver, spleen, stomach, kidney and tumor were investigated. The antitumor effect of the targeted ursolic acid liposomes (F-PEG-L-UA) on human epidermoid carcinoma xenografts in nude mice was also studied. RESULTS Compared with free ursolic acid liposome, UA liposome was slowly removed from blood circulation and the concentration of F-PEG-L-UA in liver, kidney and tumor tissue is significantly higher than other groups. The growth speed of tumor in the group of F-PEG-L-UA was significantly slowed down compared with other groups. The tumor volume in F-PEG-L-UA group was about 50% reduction compared with PBS-treated mice (P<0.05). CONCLUSION A novel targeted ursolic acid compound is synthesized as the folate receptor targeting functional material. It has obvious inhibitory effect on human epidermoid carcinoma xenografts and it might be an effective antitumor drug delivery system.
���, ������. �����ܹ���֬��������ڷֲ������������ֲ������������[J]. �й�ҩѧ��־, 2017, 52(3): 212-216.
YANG Guang, CHEN Xiao-qing. Distribution in the Body of Targeted Ursolic Acid Liposomes and Their Inhibitory Effect on Mice Transplanted Tumor. Chinese Pharmaceutical Journal, 2017, 52(3): 212-216.
DEVITA V T. Dose-response in alive and well[J]. J Clin Oncol, 1986,4(5):1157-1159.
[2]
LIU J. Oleanolic acid and ursolic acid:research perspectives [J]. J Ethnopharmacol,2005,100(1-2):92-94.
[3]
SAEIDNIA S,GOHARI A R,UCHIYAMA N,et al. Trypanocidal terpenoids from Dracocephalum kotschyi [J]. Chem Pharm Bull,2004,52(10):1249-1250.
[4]
XIONG B, LEI Z Y, CHEN H. Research progress on ursolic acid pharmacology[J]. Foreign Med(Sci Pharm),2004,31(3):133-136.
[5]
LIU X S,JIANG J. Induction of apoptosis and regulation of the MAPK pathway by ursolic acid in human leukemia K562 cells [J]. Planta Med,2007,73(11):1192-1194.
[6]
MANU K A,KUTTAN G. Ursolic acid induces apoptosis by activating p53 and caspase-3 gene expressions and suppressing NFkappaB mediated activation of bcl-2 in B16F-10 melanoma cells [J]. Int Immunopharmacol,2008,8(7):974-981.
[7]
ACHIWA Y, HASEGAWA K, KOMIYA T, et al. Ursolic acid induces Bax-dependent apoptosis through the caspase-3 pathway in endometrial cancer SNG-�� cells [J]. Oncol Rep,2005,13 (1):51-57.
[8]
OFELIA C, FLORIN B. Syntheses of new cyclodextrin complexes with oleanolic and ursolic acids [J]. Journal of Agroalimentary Processes and Technologies,2011,17(4):405-409.
[9]
ZHAO Y. Inchoate Clinical Research on Ursolic Acid Liposomes, a Natural Antitumor Drug [D]. Tianjin:Tianjin University,2012-04.
[10]
YANG G, TAN Y. In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome[J]. J Agric Food Chem, 2014, 62(10):2207-2215.
[11]
ZHAO C C, QIAN Z Z, WANG Q H, et al. A phase �� clinical trial of ursolic acid nanoliposome for evaluating its single-dose tolerance and safety[J]. Chin J New Drugs(�й���ҩ��־),2011, 20(2):148-151.
[12]
WU X H, LI Z H, WANG H M, et al. Inhibition of lung cancer by transfer of P53 gene using Tie2-rnediated gene delivery system[J]. Tumor, 2007, 27(5):256-259.
[13]
TSAI B Y, LIN Y L, CHIANG B L. Autoimmune response induced by dendritic cell exerts anti-tumor effect in murine model of leukemia[J]. J Autoimmu, 2010, 34(7):364-370.
[14]
SOUKAINA R L, HARIVARDHAN R, AMOR H. Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer[J]. Nanomedicine, 2011, 7(6):841-849.
[15]
SARASWAT B, VISEN P K, AGARWAL D P. Ursolic acid isolated from eucalyptus tereticomis protects against ethanol toxicity in isolated rat hepatocytes [J]. Phytother Res, 2000, 14(3):163-166.
[16]
MIURA N, MATSUMOTO Y, MIYAIRI S, et al. Protective effects of triterpene compounds against the cytotoxicity of cadmiumin HepG2 cells [J]. Mol Pharmacol, 1999, 56(6):1324-1328.
2017, Vol. 52 
